A strategy for managing recombinant human Factor VIIa (NovoSeven®) off-label use in the academic hospital setting

被引：0
|
作者：
Harris, SB [1 ]
Lögdberg, LE [1 ]
机构：
[1] Emory Univ, Sch Med, Atlanta, GA 30322 USA
来源：
TRANSFUSION | 2005年 / 45卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：159A / 159A
页数：1
相关论文
共 50 条
  • [31] OFF LABEL USE OF RECOMBINANT FACTOR VIIA IN THE HAEMATOLOGY WARD
    Rajic, V.
    Popovic, L.
    Savic, A.
    Savic, I.
    Urosevic, M.
    Zeravica, B.
    Agic, D.
    Vlaisavljevic, N.
    Percic, I.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 : 680 - 680
  • [32] Off-label use of recombinant factor VIIa for treatment of haemorrhage: results from randomized clinical trials
    Johansson, P. I.
    VOX SANGUINIS, 2008, 95 (01) : 1 - 7
  • [33] Off-label use of recombinant factor VIIa for treatment of haemorrhage: results from randomized clinical trials
    Hawksworth, J. S.
    Elster, E. A.
    Fryer, D.
    Sheppard, F.
    Morthole, V.
    Krishnamurthy, G.
    Tomori, T.
    Brown, T. S.
    Tadaki, D. K.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2009, 7 (10) : 1663 - 1671
  • [34] Off-Label Recombinant Factor VIIa Use and Thrombosis in Children: A Multi-Center Cohort Study
    Witmer, Char M.
    Huang, Yuan-Shung
    Lynch, Kevin
    Raffini, Leslie J.
    Shah, Samir S.
    JOURNAL OF PEDIATRICS, 2011, 158 (05): : 820 - U155
  • [35] Use of recombinant factor VIIa (NovoSeven®) in patients with Glanzmann thrombasthenia
    Poon, MC
    d'Oiron, R
    Hann, I
    Négrier, C
    de Lumley, L
    Thomas, A
    Karafoulidou, A
    Demers, C
    Street, A
    Huth-Kühne, A
    Petrini, P
    Fressinaud, E
    Morfini, M
    Tengborn, L
    Marquès-Verdier, A
    Musso, R
    Devecioglu, O
    Houston, DS
    Lethagen, S
    Van Geet, C
    von Depka, M
    Berger, C
    Beurrier, P
    Britton, HA
    Gerrits, W
    Guthner, C
    Kuhle, S
    Lorenzo, JJ
    Makris, PE
    Nohe, N
    Paugy, P
    Pautard, B
    Torchet, MF
    Trillot, N
    Vicariot, M
    Wilde, J
    Winter, M
    Chambost, H
    Ingerslev, J
    Peters, M
    Strauss, G
    SEMINARS IN HEMATOLOGY, 2001, 38 (04) : 21 - 25
  • [36] Outcomes After off-Label use of Recombinant Factor VIIa for Severe Bleeding in Pediatric Hematology/Oncology Patients
    Shayeb, Akram Mesleh
    Su, Yin
    Kang, Guolian
    Elbahlawan, Lama
    Reiss, Ulrike
    PEDIATRIC BLOOD & CANCER, 2017, 64 : S10 - S10
  • [37] Off-label use of recombinant factor VIIa (rFVIIa) for postoperative hematuria in a factor VII deficient renal transplant patient.
    Gloster, E
    Strauss, R
    DaCosta, M
    Essex, D
    Distant, D
    Braverman, A
    BLOOD, 2000, 96 (11) : 82B - 83B
  • [38] Use of recombinant factor VIIa (NovoSeven) in a haemophilia A patient with inhibitor in Kuwait
    Kanyike, FB
    Abdul-Salam, SA
    Prakash, B
    Sharhan, A
    Wahib, N
    Youssef, AH
    HAEMOPHILIA, 1999, 5 (04) : 273 - 275
  • [39] A multicenter assessment of recombinant factor VIIa off-label usage: clinical experiences and associated outcomes
    MacLaren, R
    Weber, LA
    Brake, H
    Gardner, MA
    Tanzi, M
    TRANSFUSION, 2005, 45 (09) : 1434 - 1442
  • [40] Off-Label Utilization Trend for Recombinant Factor VIIa in Children's Hospitals in the United States
    Gupta, Shveta
    Stanek, Joseph R.
    O'Brien, Sarah H.
    BLOOD, 2019, 134
12345